SNDX
SNDX
US87164F1057
Syndax Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 172.352.000 23.680.000
627.8%
Cost of Revenue 6.970.000 826.000
743.8%
Gross Profit 165.382.000 22.854.000
623.6%
438.466.000 362.526.000
20.9%
Operating Income -273.084.000 -339.672.000
19.6%
Pretax Income -285.422.000 -318.758.000
10.5%
Net Income Common Stockholders -285.422.000 -318.758.000
10.5%
-- --
--
-- --
--
ende